clinical trial · NCT06445673
A Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary Arterial Hypertension (PAH) Patients
AOP Orphan Pharmaceuticals AG·—·enrolling by invitation·n = 110
Pulmonary Arterial Hypertension
brief summary
The goal of this observational study is to learn about the long-term development and outcomes of different treatment patterns of patients who initially participated in the TripleTRE study. The primary objective of this non-interventional follow-up study is to assess the long-term real-world clinical outcomes, including disease progression and survival rates, in patients who initially participated in and completed the randomized TripleTRE trial. Planned observation duration per patient is a minimum of 3 years.
started
Jul 31, 2024
primary completion
Jun 1, 2030
completion
Jun 1, 2030
last updated
Aug 7, 2024
official title
A Prospective, Multicenter, International Non-interventional, Observational Cohort Study to Observe Long-term Treatment Patterns and Real-word Outcomes in PAH Group I Patients Previously Participating in TripleTRE - TripleTRE-NIS
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol